A motion was filed in the EU patent system to transfer the pending patent to "stromacell." Yet Regen is still borrowing intellicells technology as per the dermatology website
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.